-
9221por Brochado-Kith, Óscar, Martínez, Isidoro, Berenguer, Juan, González-García, Juan, Salgüero, Sergio, Sepúlveda-Crespo, Daniel, Díez, Cristina, Hontañón, Víctor, Ibañez-Samaniego, Luis, Pérez-Latorre, Leire, Fernández-Rodríguez, Amanda, Ángeles Jiménez-Sousa, María, Resino, Salvador“…Hepatitis C virus (HCV) cure after all-oral direct-acting antiviral (DAA) therapy greatly improves the liver and immune system. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9222por Gómez Camarero, Judith, Badia Aranda, Ester, Quiñones Castro, Raisa, Saiz Chumillas, Rosa María, Alcoba Vega, Laura, Díez Ruiz, Sandra, Gómez Manero, Noemí, Vinuesa Campo, Raquel, Jorquera Plaza, Francisco“…CONCLUSION: Screening of hepatitis C infection in hospitalized COVID-19 patients seems less useful than expected. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9223por Nguyen, Tran, Pham, Trang, Tang, Hong K, Phan, Loc, Mize, Gary, Lee, William M, Gish, Robert, Trang, Amy, Le, Anh, Phan, Hai T, Nguyen, Binh T, Dao, Doan Y“…OBJECTIVES: Vietnam is an endemic area for hepatitis B virus and hepatitis C virus infection (HBV-HCV), yet its largest city, Ho Chi Minh City (HCMC), has no comprehensive policy to educate, screen, treat and protect healthcare workers (HCWs) from viral hepatitis. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9224por Gómez Camarero, Judith, Badia Aranda, Ester, Quiñones Castro, Raisa, Saiz Chumillas, Rosa María, Alcoba Vega, Laura, Díez Ruiz, Sandra, Gómez Manero, Noemí, Vinuesa Campo, Raquel, Jorquera Plaza, Francisco“…CONCLUSION: Screening of hepatitis C infection in hospitalized COVID-19 patients seems less useful than expected. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9225por Tangvoraphonkchai, Kawin, Suttichaimongkol, Tanita, Kularbkaew, Churairat, Sangaimwibool, Prakasit, Sukeepaisarnjaroen, Wattana“…The current study evaluates the marker among healthy donors and hepatitis C (HCV) patients. 100 HCV subjects were evaluated by liver biopsy. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9226“…III degree liver injury occurred during the treatment, and the liver function returned to normal range after anti-hepatitis C treatment, which did not affect the continued treatment of this regimen.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9227por Zhang, Hedong, Liu, Qiuhao, Hu, Shanbiao, Zhong, Mingda, Peng, Fenghua, Guo, Yong, Fang, Chunhua, Nie, Manhua, Tan, Liang, Dai, Helong, Xie, Xubiao, Peng, Longkai, Lan, Gongbin“…BACKGROUND: Owing to the advent of pangenotypic direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) treatment, utilization of HCV-infected deceased donor kidneys with simplified genotyping/subtyping-free sofosbuvir/velpatasvir (SOF/VEL) treatment strategy is now becoming a promising strategy for expanding the organ donor pool. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9228por Steffen, G, Weber, C, Cawley, C, Leicht, A, Sarma, N, Jansen, K, Kröger, S, Kajikhina, K, Zimmermann, R, Bremer, V“…Serological/molecular testing from venous blood samples was performed for Hepatitis B (HBV), Hepatitis C (HCV), HIV, syphilis and TB and from urine for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9229por Nguyenla, Xammy, Wehri, Eddie, Van Dis, Erik, Biering, Scott B., Yamashiro, Livia H., Zhu, Chi, Stroumza, Julien, Dugast-Darzacq, Claire, Graham, Thomas G. W., Wang, Xuanting, Jockusch, Steffen, Tao, Chuanjuan, Chien, Minchen, Xie, Wei, Patel, Dinshaw J., Meyer, Cindy, Garzia, Aitor, Tuschl, Thomas, Russo, James J., Ju, Jingyue, Näär, Anders M., Stanley, Sarah, Schaletzky, Julia“…Strongest effects were observed with established antivirals, Hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitors velpatasvir and elbasvir. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9230por Tilloeva, Zulfiya Haybullo, Sijotkhonov, Amidkhan S, Zikriyarova, Sanam, Pirmahmadzoda, Bobochon, Alaverdyan, Sevak, Nabirova, Dilyara, Horth, Roberta, Dzhafarov, Navruz“…Closer follow-up of patients with combined resistance, alcohol or drug use, HIV, hepatitis C, and concomitant diseases may contribute to successful outcome. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9231“…BACKGROUND: Significant decreases in hepatitis B virus (HBV) and hepatitis C virus (HCV) infections have been observed in China, but both remain leading public health challenges. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9232por Hamada, Toru, Katsuta, Tomoya, Aibara, Kento, Nozu, Shohei, Nakamura, Junya, Kondo, Haruka, Tachibana, Sayaka, Inoue, Koji, Nakanishi, Norihiko, Moritaka, Tomonori“…We present the case of a 71-year-old woman with ABPA who was diagnosed with hepatitis B and active hepatitis C, and sputum analysis revealed the presence of bacteria. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9233“…When a patient with cryoglobulinemic vasculitis develops a concurrent liver disease, it is typically associated with hepatitis C. Here, we report the case of a patient with cryoglobulinemic vasculitis and autoimmune hepatitis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9234“…Hepatitis C virus (HCV) infection is a major worldwide public health concern. …”
Enlace del recurso
Enlace del recurso
Texto -
9235“…These siRNAs are expected to resist viral mutational escape, since their highly conserved targets likely contain structurally/functionally constrained elements. siVirus will be a useful tool for designing optimal siRNAs targeting highly divergent pathogens, including human immunodeficiency virus (HIV), hepatitis C virus (HCV), influenza virus and SARS coronavirus, all of which pose enormous threats to global human health.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
9236“…The mechanisms by which the hepatitis C virus (HCV) establishes persistence are not yet fully understood. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
9237“…This paper examines the role of selective serotonin reuptake inhibitors (SSRIs) in the treatment of hepatitis-C virus (HCV) patients who have developed interferon-α induced depression. …”
Enlace del recurso
Enlace del recurso
Texto -
9238por García-Muñoz, R., Rodríguez-Otero, P., Galar, A., Merino, J., Beunza, J. J., Páramo, J. A., Lecumberri, R.“…CD57+ T cells increase in several viral infections like cytomegalovirus, herpesvirus, parvovirus, HIV and hepatitis C virus and are associated with several clinical conditions related to immune dysfunction and ageing. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
9239“…Epidemiological, preclinical and clinical studies demonstrated that chronic inflammation induced by hepatitis C virus (HCV) is crucial in hepatocellular carcinogenesis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
9240“…Additionally, genome-wide association studies have looked at hepatitis C susceptibility in HIV-infected people, and genetic studies are ongoing for coronary artery disease, osteoporosis, and neurocognitive dysfunction. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto